Alendronate Sodium Industry Trends, Shares and Analysis Report by Radiant Insights, Inc
The alendronate sodium market is projected to experience a significant growth rate during the forecast period (2015-2020). The high growth rate can be ascribed to the compound being a vital ingredient in many medicines.
San Francisco, United States – July 28, 2016 /MarketersMedia/ —
Alendronate sodium is a drug which belongs to a medicine group called bisphosphonates. It contains alendronate monosodium salt and minimal amounts of starch, mannitol, magnesium stearate, microcrystalline cellulose, and sodium starch glycoate.
It was introduced in the market to treat osteoporosis in men and women. It goes by the name of Fosamax. It is also used to treat Paget’s disease and reduce bone mass. Side-effects of taking this drug include heartburn, pain in legs & chest, and numbness.
Browse Full Research Report With TOC:
http://www.radiantinsights.com/research/global-and-chinese-alendronate-sodium-industry-2015-market-research-report
The alendronate sodium market is projected to experience a significant growth rate during the forecast period (2015-2020). The high growth rate can be ascribed to the compound being a vital ingredient in many medicines. The advent of other lifestyle-related diseases such as insomnia and rheumatoid arthritis will be a prime factor influencing market growth. Toxic nature of the drug can pose a challenge to industry growth.
Product types include freeze-dried powder and injections. Hospitals, clinics, and others constitute as major market applications. Hospitals will record a decent demand for the drug in the forecast period. It has been recommended by doctors to treat osteoporosis and reduce bone resorption. The drug combined with nanoparticles is expected to improve bone regeneration. This could prove to be beneficial to the alendronate sodium industry.
See More Reports of This Category by Radiant Insights:
http://www.radiantinsights.com/catalog/pharmaceuticals-and-healthcare
Regions covered under the market are USA, UK, Japan, Australia, Germany, Switzerland, Singapore, Canada, and Italy. USA will lose market shares due to lethal side-effects of the drug causing discontent among patients. UK, Switzerland, and Germany will experience sluggish growth due to the tough market regulations.
Prominent manufacturers in the global alendronate sodium market are Xi’an Miracle Biotechnology Co., Ltd., Sigma-Aldrich, Cayman Chemical Company, and Merck Sharp & Dohme (MSD) Pty Ltd. The global market is competitive in nature. New participants can gain an entry to the market as drug patents of major pharmaceutical companies have reached their expiry dates.
Request A Sample Copy Of This Report at:
http://www.radiantinsights.com/research/global-and-chinese-alendronate-sodium-industry-2015-market-research-report/request-sample
About Radiant Insights,Inc
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
For more information, please visit http://www.radiantinsights.com/research/global-and-chinese-alendronate-sodium-industry-2015-market-research-report
Contact Info:
Name: Michelle Thoras
Email: sales@radiantinsights.com
Organization: Radiant Insights, Inc
Address: 28 2nd Street, Suite 3036, San Francisco, CA 94105, United States
Phone: 1-415-349-0054
Release ID: 125524
Copyright © 1999-2013 SproutNews.com
